Calyxt identifies more than 15,000 unique chemical signatures in lab-scale BioFactory production run

In Minnesota, Calyxt, Inc., a plant-based synthetic biotechnology company, completed a key milestone in its lab-scale BioFactory manufacturing system with results through the Company’s metabolomics analyses indicating over 15,000 chemical signatures, including both known and as-yet-uncharacterized molecules and building block precursors, chemical compounds involved in chemical reactions that produce other compounds. These chemical signatures form a baseline library available for Calyxt to produce valuable compounds within its proprietary plant-based biomanufacturing system.

This forms a baseline library of chemistries and building block precursors available for valuable downstream markets like cosmetics, nutraceuticals, and pharmaceuticals.

The Pilot BioFactory remains on track to be operational by end of 2021

The metabolomics analyses have identified molecules across a diverse and valuable group of chemical classes including terpenoids, flavonoids, phenolics, alkaloids, and sterols, plus chemical signatures that may represent new, previously uncharacterized plant-based molecules. In addition, Calyxt has recently completed gene-expression profiling that has identified patterns of genes that can be used to engineer precursor molecules for conversion to an even broader suite of chemistries.